Comparing Nasonex vs Ryaltris
| Nasonex (mometasone) | Ryaltris (mometasone / olopatadine) |
|
|---|
| Nasonex (mometasone) | Ryaltris (mometasone / olopatadine) |
|
|||||||
|---|---|---|---|---|---|---|---|---|---|
|
Prescription only
Prescribed for Sinus Symptoms, Allergic Rhinitis, Nasal Polyps. Nasonex may also be used for purposes not listed in this medication guide. |
Prescription only
Prescribed for Allergic Rhinitis. Ryaltris may also be used for purposes not listed in this medication guide. |
Related suggestions Allergic Rhinitis
Popular comparisons
|
|||||||
| More about (mometasone) | More about Ryaltris (mometasone / olopatadine) | ||||||||
| Ratings & Reviews | |||||||||
|
Nasonex has an average rating of 5.2 out of 10 from a total of 86 ratings on Drugs.com. 40% of reviewers reported a positive effect, while 45% reported a negative effect. |
Ryaltris has an average rating of 7.5 out of 10 from a total of 4 ratings on Drugs.com. 50% of reviewers reported a positive effect, while 0% reported a negative effect. |
||||||||
| Side Effects Experienced by Users Side effects are reported in Drugs.com user reviews and not clinically verified. | |||||||||
View all Nasonex side effects |
View all Ryaltris side effects |
||||||||
| Drug Class | |||||||||
| Generic Availability | |||||||||
| Lower cost generic approved |
N/A |
||||||||
| Pricing and Coupons * Prices are without insurance | |||||||||
|
We could not find an exact match for this medicine. Try searching the Price Guide directly. |
View all Ryaltris prices |
||||||||
| Dosage Forms | |||||||||
|
|
||||||||
| Brand Names | |||||||||
| Other mometasone brands include: Nasonex 24HR Allergy, Nasonex Children’s 24HR Allergy, Propel, Propel Mini, Sinuva |
N/A |
||||||||
| Half Life Drug half-life is the time required for plasma concentration to reduce to half its original value. | |||||||||
|
5.8 hours |
12 hours (empirically) |
||||||||
| CSA Schedule 1 View glossary of CSA terms | |||||||||
|
Not a controlled drug
Is not subject to the Controlled Substances Act. |
Not a controlled drug
Is not subject to the Controlled Substances Act. |
||||||||
| Pregnancy Category | |||||||||
|
Category C
Risk cannot be ruled out
See the full pregnancy warnings document. |
Summary unavailable. See the full pregnancy warnings document. |
||||||||
| Drug Interactions | |||||||||
|
A total of 34 drugs are known to interact with Nasonex:
|
A total of 317 drugs are known to interact with Ryaltris:
|
||||||||
| Alcohol/Food/Lifestyle Interactions | |||||||||
|
No known alcohol/food interactions. This does not necessarily mean no interactions exist. Always consult your healthcare provider. |
|
||||||||
| Disease Interactions | |||||||||
| First Approval Date | |||||||||
|
N/A |
N/A |
||||||||
| WADA Class View classifications | |||||||||
| More Information | |||||||||
| Patient Resources | |||||||||
|
N/A |
|||||||||
| Professional Resources | |||||||||
|
N/A |
|||||||||
| Related Treatment Guide | |||||||||
1 The Controlled Substances Act (CSA) schedule information displayed applies to substances regulated under federal law. There may be variations in CSA schedules between individual states.
See also:
Nasonex 24HR Allergy
Nasonex 24HR Allergy (mometasone) is used to treat nasal allergies such as congestion, sneezing ...
Ozempic
Learn about Ozempic (semaglutide) for type 2 diabetes treatment, weight management, cardiovascular ...
Conex
Conex is used for allergic rhinitis, cold symptoms, nasal congestion, sinus symptoms
Alka-Seltzer Plus Cold
Alka-Seltzer Plus Cold is used for cold symptoms, sinus symptoms
Guaifenesin/phenylephrine
Guaifenesin/phenylephrine is used for cough and nasal congestion, sinus symptoms
Acetaminophen/dextromethorphan/phenylephrine
Acetaminophen/dextromethorphan/phenylephrine is used for cold symptoms, cough, cough and nasal ...
Naproxen/pseudoephedrine
Naproxen/pseudoephedrine is used for nasal congestion, pain/fever, sinus symptoms
Ibuprofen/pseudoephedrine
Ibuprofen/pseudoephedrine is used for sinus symptoms
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.